Vumerity DR 231 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F0N4X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,382
Award facts
- Contract value 100% obligated
- $22,381.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $22,381.87 delivery order to Amerisourcebergen Drug Corp on April 28, 2026, for Vumerity (dimmesylate) 231 mg capsule 120-count units.
Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 29, 2026. No set-aside was used. This delivery order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical prime vendor supply to military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26F0N4X?
SPE2DR26F0N4X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 28, 2026.
How much is contract SPE2DR26F0N4X worth?
The government has obligated $22,382 on SPE2DR26F0N4X.
Is contract SPE2DR26F0N4X an order under another contract?
Yes. SPE2DR26F0N4X is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0N4X competed?
The extent of competition for SPE2DR26F0N4X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award